Correlation Between GMS and Dianthus Therapeutics

Can any of the company-specific risk be diversified away by investing in both GMS and Dianthus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GMS and Dianthus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GMS Inc and Dianthus Therapeutics, you can compare the effects of market volatilities on GMS and Dianthus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GMS with a short position of Dianthus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GMS and Dianthus Therapeutics.

Diversification Opportunities for GMS and Dianthus Therapeutics

0.07

Correlation Coefficient

GMS  Dianthus Therapeutics

Significant diversification

The 3 months correlation between GMS and Dianthus is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding GMS Inc and Dianthus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dianthus Therapeutics and GMS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GMS Inc are associated (or correlated) with Dianthus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dianthus Therapeutics has no effect on the direction of GMS i.e., GMS and Dianthus Therapeutics go up and down completely randomly.

Pair Corralation between GMS and Dianthus Therapeutics

Considering the 90-day investment horizon GMS Inc is expected to under-perform the Dianthus Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, GMS Inc is 2.64 times less risky than Dianthus Therapeutics. The stock trades about -0.69 of its potential returns per unit of risk. The Dianthus Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  2,468  in Dianthus Therapeutics on October 5, 2024 and sell it today you would earn a total of  44.00  from holding Dianthus Therapeutics or generate 1.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

GMS Inc  vs.  Dianthus Therapeutics

GMS Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GMS Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's primary indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Dianthus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Dianthus Therapeutics is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with GMS and Dianthus Therapeutics

The main advantage of trading using opposite GMS and Dianthus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GMS position performs unexpectedly, Dianthus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dianthus Therapeutics will offset losses from the drop in Dianthus Therapeutics' long position.

The idea behind GMS Inc and Dianthus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.